查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1762435

法布瑞氏症治疗市场规模、占有率及产业分析报告：依给药途径、治疗方法、通路、地区，预测至2025-2034年

Fabry Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2034年，法布瑞氏症治疗市场规模将达到53.2112亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

法布瑞氏症治疗市场致力于开发和商业化目的是控制法布瑞氏症临床症状的疗法。法布瑞氏症是一种由α-半乳糖苷酶A缺乏所引起的罕见X连锁溶小体贮积症。这种酵素缺乏会导致神经酰胺三己糖苷（Gb3）在体内蓄积，进而对肾臟、心臟和神经系统等重要器官造成渐进性损害。靶向酶替代疗法（ERT）的进展以及目的是稳定错误折迭酶的口服伴侣疗法日益普及，共同推动市场的发展。医疗保健提供者意识的提高和诊断能力的提升，有助于更早发现并扩大治疗覆盖范围。对罕见疾病研究的策略性投资推动创新，并加速监管审批，包括罕见疾病药物和精准医疗平台的发展。市场参与者越来越关注具有持久或潜在治癒潜力的基因治疗产品线，这反映了向下一代疗法迈进的重要趋势。

偿付框架的改进以及生物製药公司与学术机构之间的合作研究计划，为差异化治疗方案的开发创造了新的机会。此外，针对晚发性和非典型表型的客製化治疗方案的开发也日益受到重视，以满足不同患者亚群中尚未满足的需求。透过上市后监测和真实世界证据生成，加强对长期疗效和安全性的监测，为治疗选择增添了信心。整体而言，市场呈现动态格局，其特点是未满足需求高、临床复杂性高，以及生物製剂和小分子疗法的强劲创新动力。

法布瑞氏症治疗市场报告重点

依给药途径，静脉给药在2024年占最大占有率。静脉给药是酵素替代疗法（ERT）在法布瑞氏症治疗中的主要给药方式。

依治疗方法，酵素替代疗法（ERT）在2024年占据约60%的占有率。 ERT包括静脉注射合成酶，例如阿加糖酶α和β，这些酶有助于分解Gb3，减缓疾病进展并缓解神经性疼痛、胃肠道疾病和器官功能障碍等症状。

2024年，亚太地区法布瑞氏症治疗市场占据最大占有率，这得益于该地区人们对罕见遗传疾病的认识不断提高以及诊断基础设施的不断扩展。

预计拉丁美洲法布瑞氏症治疗市场将在2025年至2034年间大幅成长。拉丁美洲的医疗保健提供者、政府和援助组织优先考虑早期诊断和治疗，刺激了该地区市场的扩张。

全球领先的公司包括Amicus Therapeutics, Inc.、CANbridge Life Sciences Ltd.、Chiesi Farmaceutici S.p.A.、Idorsia Pharmaceuticals Ltd.、ISU ABXIS Co., Ltd.、JCR Pharmaceuticals Co., Ltd.、Protalix Biotherapeutics Inc.、Sangamo Therapeutics, Inc.、Sanofi、Takeda Pharmaceutical。

目录

第1章 介绍

第2章 执行摘要

第3章 研究方法

第4章 全球法布瑞氏症治疗市场洞察

  • 市场概况
  • 法布瑞氏症治疗市场动态
    • 驱动因素与机会
      • 个人化医疗在法布瑞氏症治疗的引进
      • 偿付政策的扩大
    • 限制因素与挑战
      • 熟练劳动力短缺
  • PESTEL 分析
  • 法布瑞氏症治疗市场趋势
  • 价值链分析

第5章 全球法布瑞氏症治疗市场（依给药途径）

  • 主要调查结果
  • 简介
  • 静脉注射
  • 口服

第6章 全球法布瑞氏症治疗市场（依治疗方法）

  • 主要调查结果
  • 简介
  • 酵素替代疗法（ERT）
  • 底物减少疗法（SRT）
  • 其他

第7章 全球法布瑞氏症治疗市场（依通路）

  • 主要调查结果
  • 简介
  • 医院药房
  • 零售药房
  • 网路药房

第8章 全球法布瑞氏症治疗市场（依地区）

  • 主要调查结果
  • 介绍
    • 2020-2034年法布瑞氏症治疗市场各地区评估
  • 北美
    • 2020-2034年北美：依给药途径
    • 2020-2034年北美：依治疗方法
    • 2020-2034年北美：依通路
    • 美国
    • 加拿大
  • 欧洲
    • 2020-2034年欧洲：依给药途径
    • 2020-2034年欧洲：依治疗方法
    • 2020-2034年欧洲：依通路
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 欧洲其他地区
  • 亚太地区
    • 2020-2034年亚太地区：依给药途径
    • 2020-2034年亚太地区：依疗法
    • 2020-2034年亚太地区：依通路
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东和非洲
    • 2020-2034年中东及非洲：依给药途径
    • 2020-2034年中东及非洲：依疗法
    • 2020-2034年中东与非洲：依通路
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 中东和非洲其他地区
  • 拉丁美洲
    • 2020-2034年拉丁美洲：依给药途径
    • 2020-2034年拉丁美洲：依疗法
    • 2020-2034年拉丁美洲：依通路
    • 墨西哥
    • 巴西
    • 阿根廷
    • 拉丁美洲其他地区

第9章 竞争格局

  • 扩张与收购分析
    • 扩张
    • 收购
  • 合作伙伴/合作/协议/公开

第10章 公司简介

  • Amicus Therapeutics, Inc.
  • CANbridge Life Sciences Ltd.
  • Chiesi Farmaceutici S.p.A.
  • Idorsia Pharmaceuticals Ltd.
  • ISU ABXIS Co., Ltd.
  • JCR Pharmaceuticals Co., Ltd.
  • Protalix Biotherapeutics Inc.
  • Sangamo Therapeutics, Inc.
  • Sanofi
  • Takeda Pharmaceutical
Product Code: PM5760

The fabry's disease treatment market size is expected to reach USD 5,321.12 million by 2034, according to a new study by Polaris Market Research. The report "Fabry's Disease Treatment Market Size, Share, & Industry Analysis Report By Route of Administration (Intravenous Route and Oral Route), By Therapy, By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Fabry's disease treatment market focuses on the development and commercialization of therapies designed to manage the clinical manifestations of Fabry disease, a rare X-linked lysosomal storage disorder caused by a deficiency of the a-galactosidase A enzyme. This enzymatic deficit leads to the systemic accumulation of globotriaosylceramide (Gb3), resulting in progressive damage to vital organs such as the kidneys, heart, and nervous system. The market is being propelled by advances in targeted enzyme replacement therapy (ERT) and the growing availability of oral chaperone therapies that aim to stabilize the misfolded enzymes. Rising awareness among healthcare providers and improved diagnostic capabilities are contributing to earlier detection, expanding the eligible treatment population. Strategic investments in rare disease research, including orphan drug development and precision medicine platforms, are fostering innovation and accelerating regulatory approvals. Market participants are increasingly focusing on gene therapy pipelines that offer the potential for durable or curative outcomes, reflecting a key trend toward next-generation modalities.

Improved reimbursement frameworks and collaborative research initiatives between biopharmaceutical companies and academic institutions are creating new opportunities for the development of differentiated treatment solutions. There is also a rising emphasis on developing treatments tailored to late-onset and atypical phenotypes, addressing unmet needs in diverse patient subgroups. Increasing efforts to monitor long-term efficacy and safety through post-marketing surveillance and real-world evidence generation are reinforcing confidence in therapeutic choices. Overall, the market reflects a dynamic landscape marked by high unmet need, significant clinical complexity, and a robust drive toward innovation in both biologic and small-molecule therapies.

Fabry's Disease Treatment Market Report Highlights

By route of administration, in 2024, the intravenous route segment accounted for the largest share. Intravenous (IV) administration is the primary method for delivering enzyme replacement therapy (ERT) in Fabry disease treatment.

Based on therapy, in 2024, the enzyme replacement therapy (ERT) segment accounted for approximately 60% of the share. ERT involves intravenous infusions of synthetic enzymes such as agalsidase alfa or beta, which help break down Gb3, slowing disease progression and alleviating symptoms such as neuropathic pain, gastrointestinal issues, and organ dysfunction.

In 2024, the Asia Pacific Fabry's disease treatment market accounted for the largest share due to increasing awareness of rare genetic disorders and the expansion of diagnostic infrastructure in the region.

The Latin America Fabry's disease treatment market is projected to grow significantly from 2025 to 2034. Healthcare providers, governments, and advocacy groups in LATAM are prioritizing early diagnosis and access to therapies, fueling the regional market expansion.

A few global key players include Amicus Therapeutics, Inc.; CANbridge Life Sciences Ltd.; Chiesi Farmaceutici S.p.A.; Idorsia Pharmaceuticals Ltd.; ISU ABXIS Co., Ltd.; JCR Pharmaceuticals Co., Ltd.; Protalix Biotherapeutics Inc.; Sangamo Therapeutics, Inc.; Sanofi; and Takeda Pharmaceutical.

Polaris Market Research has segmented the Fabry's disease treatment market report on the basis of route of administration, therapy, distribution channel, and region:

By Route of Administration Outlook (Revenue, USD Million, 2020-2034)

Intravenous Route

Oral Route

By Therapy Outlook (Revenue, USD Million, 2020-2034)

Enzyme Replacement Therapy (ERT)

Substrate Reduction Therapy (SRT)

Others

By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Fabry's Disease Treatment Market Insights

  • 4.1. Fabry's Disease Treatment Market - Market Snapshot
  • 4.2. Fabry's Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Personalized Medicine Adoption in Fabry Disease Care
      • 4.2.1.2. Expansion of Reimbursement Policies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Shortage of Skilled Personal
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Fabry's Disease Treatment Market Trends
  • 4.6. Value Chain Analysis

5. Global Fabry's Disease Treatment Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • 5.3. Intravenous Route
    • 5.3.1. Global Fabry's Disease Treatment Market, by Intravenous Route, by Region, 2020-2034 (USD Million)
  • 5.4. Oral Route
    • 5.4.1. Global Fabry's Disease Treatment Market, by Oral Route, by Region, 2020-2034 (USD Million)

6. Global Fabry's Disease Treatment Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • 6.3. Enzyme Replacement Therapy (ERT)
    • 6.3.1. Global Fabry's Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD Million)
  • 6.4. Substrate Reduction Therapy (SRT)
    • 6.4.1. Global Fabry's Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Fabry's Disease Treatment Market, by Others, by Region, 2020-2034 (USD Million)

7. Global Fabry's Disease Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Fabry's Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Fabry's Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Fabry's Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Million)

8. Global Fabry's Disease Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Fabry's Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Million)
  • 8.3. Fabry's Disease Treatment Market - North America
    • 8.3.1. North America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.3.2. North America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.3.3. North America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.4. Fabry's Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.4.2. U.S.: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.4.3. U.S.: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.3.5. Fabry's Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.3.5.2. Canada: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.3.5.3. Canada: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.4. Fabry's Disease Treatment Market - Europe
    • 8.4.1. Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.4.2. Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.4.3. Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.4. Fabry's Disease Treatment Market - UK
      • 8.4.4.1. UK: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.4.2. UK: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.4.3. UK: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.5. Fabry's Disease Treatment Market - France
      • 8.4.5.1. France: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.5.2. France: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.5.3. France: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.6. Fabry's Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.6.2. Germany: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.6.3. Germany: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.7. Fabry's Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.7.2. Italy: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.7.3. Italy: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.8. Fabry's Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.8.2. Spain: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.8.3. Spain: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.9. Fabry's Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.9.2. Netherlands: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.9.3. Netherlands: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.10. Fabry's Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.10.2. Russia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.10.3. Russia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.4.11. Fabry's Disease Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.4.11.2. Rest of Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.4.11.3. Rest of Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.5. Fabry's Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.5.2. Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.5.3. Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.4. Fabry's Disease Treatment Market - China
      • 8.5.4.1. China: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.4.2. China: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.4.3. China: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.5. Fabry's Disease Treatment Market - India
      • 8.5.5.1. India: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.5.2. India: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.5.3. India: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.6. Fabry's Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.6.2. Malaysia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.6.3. Malaysia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.7. Fabry's Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.7.2. Japan: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.7.3. Japan: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.8. Fabry's Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.8.2. Indonesia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.8.3. Indonesia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.9. Fabry's Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.9.2. South Korea: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.9.3. South Korea: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.10. Fabry's Disease Treatment Market - Australia
      • 8.5.10.1. Australia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.10.2. Australia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.10.3. Australia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.5.11. Fabry's Disease Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.5.11.2. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.5.11.3. Rest of Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.6. Fabry's Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.6.2. Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.6.3. Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.4. Fabry's Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.4.2. Saudi Arabia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.4.3. Saudi Arabia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.5. Fabry's Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.5.2. UAE: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.5.3. UAE: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.6. Fabry's Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.6.2. Israel: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.6.3. Israel: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.7. Fabry's Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.7.2. South Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.7.3. South Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.6.8. Fabry's Disease Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.6.8.2. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.6.8.3. Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • 8.7. Fabry's Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
    • 8.7.2. Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
    • 8.7.3. Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.4. Fabry's Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.4.2. Mexico: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.4.3. Mexico: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.5. Fabry's Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.5.2. Brazil: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.5.3. Brazil: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.6. Fabry's Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.6.2. Argentina: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.6.3. Argentina: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
    • 8.7.7. Fabry's Disease Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
      • 8.7.7.2. Rest of Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
      • 8.7.7.3. Rest of Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amicus Therapeutics, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CANbridge Life Sciences Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Chiesi Farmaceutici S.p.A.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Idorsia Pharmaceuticals Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. ISU ABXIS Co., Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. JCR Pharmaceuticals Co., Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Protalix Biotherapeutics Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Sangamo Therapeutics, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sanofi
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Takeda Pharmaceutical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 2 Global Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 3 Global Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 4 North America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 5 North America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 6 North America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 U.S.: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 8 U.S.: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 9 U.S.: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 10 Canada: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 11 Canada: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 12 Canada: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 14 Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 15 Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 16 UK: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 17 UK: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 18 UK: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 19 France: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 20 France: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 21 France: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 22 Germany: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 23 Germany: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 24 Germany: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 25 Italy: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 26 Italy: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 27 Italy: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 28 Spain: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 29 Spain: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 30 Spain: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 31 Netherlands: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 32 Netherlands: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 33 Netherlands: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 34 Russia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 35 Russia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 36 Russia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 37 Rest of Europe: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 38 Rest of Europe: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 39 Rest of Europe: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 40 Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 41 Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 42 Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 43 China: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 44 China: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 45 China: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 46 India: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 47 India: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 48 India: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 49 Malaysia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 50 Malaysia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 51 Malaysia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 52 Japan: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 53 Japan: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 54 Japan: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 55 Indonesia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 56 Indonesia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 57 Indonesia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 58 South Korea: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 59 South Korea: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 60 South Korea: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 61 Australia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 62 Australia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 63 Australia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 64 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 65 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 66 Rest of Asia Pacific: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 67 Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 68 Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 69 Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 70 Saudi Arabia: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 71 Saudi Arabia: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 72 Saudi Arabia: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 73 UAE: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 74 UAE: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 75 UAE: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 76 Israel: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 77 Israel: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 78 Israel: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 79 South Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 80 South Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 81 South Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 82 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 83 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 84 Rest of Middle East & Africa: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 85 Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 86 Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 87 Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 88 Mexico: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 89 Mexico: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 90 Mexico: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 91 Brazil: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 92 Brazil: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 93 Brazil: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 94 Argentina: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 95 Argentina: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 96 Argentina: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 97 Rest of Latin America: Fabry's Disease Treatment Market, by Route of Administration, 2020-2034 (USD Million)
  • Table 98 Rest of Latin America: Fabry's Disease Treatment Market, by Therapy, 2020-2034 (USD Million)
  • Table 99 Rest of Latin America: Fabry's Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Fabry's Disease Treatment Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Route of Administration
  • Figure 7. Global Fabry's Disease Treatment Market, by Route of Administration, 2024 & 2034 (USD Million)
  • Figure 8. Market by Therapy
  • Figure 9. Global Fabry's Disease Treatment Market, by Therapy, 2024 & 2034 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Fabry's Disease Treatment Market, by Distribution Channel, 2024 & 2034 (USD Million)